M. Tatar Et Al. , "COST-EFFECTIVENESS OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDERS IN TURKEY," VALUE IN HEALTH , vol.15, no.4, 2012
Tatar, M. Et Al. 2012. COST-EFFECTIVENESS OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDERS IN TURKEY. VALUE IN HEALTH , vol.15, no.4 .
Tatar, M., Dilbaz, N., Oral, E. T., & Tan, M., (2012). COST-EFFECTIVENESS OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDERS IN TURKEY. VALUE IN HEALTH , vol.15, no.4.
Tatar, MEHTAP Et Al. "COST-EFFECTIVENESS OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDERS IN TURKEY," VALUE IN HEALTH , vol.15, no.4, 2012
Tatar, MEHTAP Et Al. "COST-EFFECTIVENESS OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDERS IN TURKEY." VALUE IN HEALTH , vol.15, no.4, 2012
Tatar, M. Et Al. (2012) . "COST-EFFECTIVENESS OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDERS IN TURKEY." VALUE IN HEALTH , vol.15, no.4.
@article{article, author={MEHTAP TATAR Et Al. }, title={COST-EFFECTIVENESS OF AGOMELATINE IN TREATMENT OF MAJOR DEPRESSIVE DISORDERS IN TURKEY}, journal={VALUE IN HEALTH}, year=2012}